Max Nyström (Former)

1 – 4 of 4

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/943bde8d-f650-4e77-9911-19c803db98bd?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2003
Mark Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro.
Hollander, Camilla ^LU ; Nyström, Max ^LU ; Janciauskiene, Sabina ^LU and Westin, Ulla ^LU (2003) In Cancer Cell International 3(1).
- Contribution to journal › Article
2002
Mark Secretory Leukocyte Protease Inhibitor (SLPI) in the gastrointestinal tract in man.
Nyström, Max ^LU (2002)
- Thesis › Doctoral thesis (compilation)
Mark The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation.
Westin, Ulla ^LU ; Nyström, Max ^LU ; Ljungcrantz, Irena ^LU ; Eriksson, B and Ohlsson, K (2002) In Mediators of Inflammation 11(1). p.7-12
- Contribution to journal › Article
2001
Mark Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa
Nyström, Max ^LU ; Westin, Ulla Peterson ^LU ; Linder, Carina ^LU and Ohlsson, Kjell (2001) In Mediators of Inflammation 10(5). p.269-272
- Contribution to journal › Article